ET
EW icon

Entropy Technologies’s Edwards Lifesciences EW Stock Holding History

Entropy Technologies’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,425
Closed -$3.36M – 975
2025
Q4 		$3.36M Buy
+39,425
New +$3.24M 0.18% 158
2025
Q1 		– Sell
-14,344
Closed -$1.06M – 790
2024
Q4 		$1.06M Sell
14,344
-17,004
-54% -$1.19M 0.11% 260
2024
Q3 		$2.07M Buy
+31,348
New +$2.28M 0.22% 133
2024
Q1 		– Sell
-23,017
Closed -$1.76M – 764
2023
Q4 		$1.76M Buy
+23,017
New +$1.6M 0.33% 89

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Entropy Technologies's EW Position: Q1 2026 in Review

Entropy Technologies sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 39,425 shares — an estimated $3.36M sold.

Entropy Technologies first reported a position in EW in Q4 2023 and held it in 4 quarters. The position peaked at $3.36M in Q4 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Entropy Technologies reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • Entropy Technologies sold 39,425 Edwards Lifesciences shares in Q1 2026, an estimated $3.36M.
  • Entropy Technologies first reported a position in Edwards Lifesciences in Q4 2023 and held it in 4 quarters.
  • Entropy Technologies's Edwards Lifesciences position peaked at $3.36M in Q4 2025.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Entropy Technologies's 13F filing for Q1 2026, filed 14 May 2026.